What Is a ‘Tolerable’ Dose? AACR-Industry Roundtable 2025 Examines Dose Optimization
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
A special collection of commentaries in the AACR journal Cancer Discovery offers innovative ideas from leading Chinese researchers.
New research into potential causes of gastric cancer is looking beyond H. pylori to other bacteria within the gastric...
New advances in our understanding of cancer cachexia may provide hope for patients with pancreatic cancer.
Susan Kaech and Ton Schumacher gave thought-provoking keynotes at the AACR Special Conference in Cancer Research: Tumor Immunology and...
Recent advances in EGFR inhibition include combinations to overcome resistance and approvals for newly diagnosed or early-stage lung cancers.
A recent study on the prevalence of cancer across different vertebrate species may provide insights into cancer mechanisms in...
At the AACR Conference on the Science of Cancer Health Disparities, researchers shared results from interventions designed to help...
This month, the editors selected studies comparing CAR T therapies for large B-cell lymphoma, assessing a new type of...
This Halloween edition features ghostly transparent mice, parasites to deliver drugs to the brain, stealing from the dead, and...
The AACR Industry Roundtable 2024 focused on topics related to tracking and treating early cancers, including predicting cancer risk...